Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Eliquis Lowers Stroke Risk, But Side Effects Linked to Higher Risk of Major Bleeding: Study Although side effects of Eliquis may cause severe and uncontrollable bleeding problems, researchers indicate the blood thinner lowers the risk of stroke and systemic embolism compared to aspirin. January 17, 2024 Katherine McDaniel Add Your Comments The findings of a new study suggests that the blood thinner Eliquis (apixaban) may be better than aspirin at preventing blood clots and strokes, but side effects are more likely to cause serious bleeding problems among patients. A team of international medical researchers report that Eliquis lowers the risk of stroke and blood clots among patients with irregular heart rhythms. However, nearly one out of every 50 patients who took the drug developed major bleeding events, according to findings published on January 11 in the New England Journal of Medicine. Eliquis was introduced in 2012 as part of a new class of blood thinner medications to reduce the risk of blood clots and strokes, particularly among patients with atrial fibrillation. It was marketed as a replacement for warfarin, which has been the most commonly used blood thinner for decades. However, Eliquis was associated with severe and uncontrollable bleeding events, and lacked a reversal agent that could quickly counteract the blood thinning effects when it was first released, which led to a number of serious injuries. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Atrial fibrillation (AF) is a heart rhythm disorder, and is defined as subclinical when irregular heartbeats are only detected on an implanted pacemaker or defibrillator device. Researchers in the latest study indicate individuals who suffer from the subclinical version of the disorder face an increased risk of stroke, and warn the benefits Eliquis provides remains uncertain. Eliquis Linked to Major Bleeding Event Risks In the study, a team of medical researchers from several different countries conducted a randomized trial to see how effective Eliquis was in preventing strokes, using the data on 4,012 patients who had subclinical AF episodes lasting from six minutes to 24 hours. Participants were randomly assigned into two groups; one was prescribed 5 mg of Eliquis daily, while the other took 81 mg of aspirin daily. The medications were stopped if episodes continued for more than 24 hours, or if AF symptoms were detected without an implanted cardiac device. According to the data, 86 participants among the aspirin group suffered from a stroke or blood clot, compared to only 55 participants among the Eliquis group. The data also revealed the rate of major bleeding events reported among patients in the Eliquis group was 1.71% per year, compared to 0.94% among those in the aspirin group. “Among patients with subclinical atrial fibrillation, apixaban resulted in a lower risk of stroke or systemic embolism than aspirin but a higher risk of major bleeding,” the researchers concluded. The findings are similar to those revealed in prior research, which has linked Eliquis, Xarelto, Pradaxa and similar blood thinning medications to increased bleeding risks. It was not until a reversal agent, Andexxa, was approved for Eliquis and Xarelto in 2018, that doctors were provided a means to quickly combat the drugs’ bleeding risks. Tags: Andexxa, Atrial Fibrillation, Bleeding, Blood Thinner, Eliquis, Stroke, Warfarin, Xarelto More Lawsuit Stories Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 March 14, 2025 At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics March 14, 2025 Judge Calls for Change Healthcare Data Breach Lawsuits in State and Federal Courts To Be Coordinated March 14, 2025 1 Comments Arthur November 21, 2024 Any lawsuits against Eliquis for causing brain bleed. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: 2 days ago) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024) Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 3 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025) Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 4 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 March 14, 2025
Judge Calls for Change Healthcare Data Breach Lawsuits in State and Federal Courts To Be Coordinated March 14, 2025
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: 2 days ago) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024)
Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 3 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)
Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 4 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)